This page follows insider dealings at Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) as filed with SEDI. The past year has been quiet: not a single insider filing for Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.). The previous disclosure was published on 15 September 2016.
The full history, which starts in 2016, counts 2 purchases against no sales.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
9 of 9 declarations
Telesta Therapeutics Inc., formerly known as Bioniche Life Sciences Inc., is a biopharmaceutical company focused on developing treatments for cancer. It is listed on the XTSE market.